Increased ALKBH5 in ovarian cancer predicts poorer survival, as the high expression of ALKBH5 activates the mTOR and BLC2-Beclin1 pathways to promote proliferation, invasion, and even autophagy [168]. The gene discussed is ALKBH5; the disease is ovarian carcinoma.